RT Journal Article
SR Electronic
T1 OP.07 The pharmacological management of sleep problems: BAP guidelines
JF Journal of Neurology, Neurosurgery & Psychiatry
JO J Neurol Neurosurg Psychiatry
FD BMJ Publishing Group Ltd
SP e2
OP e2
DO 10.1136/jnnp-2011-300504.7
VO 82
IS 8
A1 S Wilson
YR 2011
UL http://jnnp.bmj.com/content/82/8/e2.41.abstract
AB Sleep disorders are common in the general population and in clinical practice, yet are relatively poorly understood by doctors and other health care practitioners. The British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders was designed to address this problem by providing an accessible up-to-date and evidence-based outline of the major issues especially those relating to reliable diagnosis and appropriate treatment. A consensus meeting was held in London in May 2009 with BAP members, representative clinicians with a strong interest in sleep disorders and recognised experts and advocates in the field from UK, mainland Europe and the USA. We limited ourselves to discussion of sleep problems that are not regarded as being secondary to respiratory problems, and did not consider certain neuropsychiatric disorders for which recent sets of guidelines already exist, such as narcolepsy and restless legs. Thus the main scope of this document is to cover insomnia, circadian rhythm disorders and the more common parasomnias which are likely to present to psychiatrists or primary care physicians.The main recommendations of the consensus document will be presented.